Amyloid PET imaging: Standardization and integration with other Alzheimer’s disease biomarkers

Silvia Morbelli, Matteo Bauckneht

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Amyloid plaques are a neuropathologic hallmark of Alzheimer’s disease (AD), which can be imaged through positron emission tomography (PET) technology using radiopharmaceuticals that selectively bind to the fibrillar aggregates of amyloid-β plaques (Amy-PET). Several radiotracers for amyloid PET have been investigated, including 11C-Pittsburgh compound B and the 18F-labeled compounds such as 18F-florbetaben, 18F-florbetapir, and 18F-flutemetamol. Besides the injected radiotracer, images can be interpreted by means of visual/qualitative, semiquantitative, and quantitative criteria. Here we summarize the main differences between the available radiotracers for Amy-PET, the proposed interpretation criteria, and analytical methods.

Original languageEnglish
Title of host publicationMethods in Molecular Biology
PublisherHumana Press Inc.
Pages203-212
Number of pages10
DOIs
Publication statusPublished - Jan 1 2018

Publication series

NameMethods in Molecular Biology
Volume1750
ISSN (Print)1064-3745

Fingerprint

Amyloid
Positron-Emission Tomography
Alzheimer Disease
Biomarkers
Amyloid Plaques
Radiopharmaceuticals
Technology

Keywords

  • Alzheimer’s disease
  • Amyloid PET
  • Biomarkers
  • Brain

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics

Cite this

Morbelli, S., & Bauckneht, M. (2018). Amyloid PET imaging: Standardization and integration with other Alzheimer’s disease biomarkers. In Methods in Molecular Biology (pp. 203-212). (Methods in Molecular Biology; Vol. 1750). Humana Press Inc.. https://doi.org/10.1007/978-1-4939-7704-8_13

Amyloid PET imaging : Standardization and integration with other Alzheimer’s disease biomarkers. / Morbelli, Silvia; Bauckneht, Matteo.

Methods in Molecular Biology. Humana Press Inc., 2018. p. 203-212 (Methods in Molecular Biology; Vol. 1750).

Research output: Chapter in Book/Report/Conference proceedingChapter

Morbelli, S & Bauckneht, M 2018, Amyloid PET imaging: Standardization and integration with other Alzheimer’s disease biomarkers. in Methods in Molecular Biology. Methods in Molecular Biology, vol. 1750, Humana Press Inc., pp. 203-212. https://doi.org/10.1007/978-1-4939-7704-8_13
Morbelli S, Bauckneht M. Amyloid PET imaging: Standardization and integration with other Alzheimer’s disease biomarkers. In Methods in Molecular Biology. Humana Press Inc. 2018. p. 203-212. (Methods in Molecular Biology). https://doi.org/10.1007/978-1-4939-7704-8_13
Morbelli, Silvia ; Bauckneht, Matteo. / Amyloid PET imaging : Standardization and integration with other Alzheimer’s disease biomarkers. Methods in Molecular Biology. Humana Press Inc., 2018. pp. 203-212 (Methods in Molecular Biology).
@inbook{3df89034fb6743388a310d47fe9c4fd5,
title = "Amyloid PET imaging: Standardization and integration with other Alzheimer’s disease biomarkers",
abstract = "Amyloid plaques are a neuropathologic hallmark of Alzheimer’s disease (AD), which can be imaged through positron emission tomography (PET) technology using radiopharmaceuticals that selectively bind to the fibrillar aggregates of amyloid-β plaques (Amy-PET). Several radiotracers for amyloid PET have been investigated, including 11C-Pittsburgh compound B and the 18F-labeled compounds such as 18F-florbetaben, 18F-florbetapir, and 18F-flutemetamol. Besides the injected radiotracer, images can be interpreted by means of visual/qualitative, semiquantitative, and quantitative criteria. Here we summarize the main differences between the available radiotracers for Amy-PET, the proposed interpretation criteria, and analytical methods.",
keywords = "Alzheimer’s disease, Amyloid PET, Biomarkers, Brain",
author = "Silvia Morbelli and Matteo Bauckneht",
year = "2018",
month = "1",
day = "1",
doi = "10.1007/978-1-4939-7704-8_13",
language = "English",
series = "Methods in Molecular Biology",
publisher = "Humana Press Inc.",
pages = "203--212",
booktitle = "Methods in Molecular Biology",

}

TY - CHAP

T1 - Amyloid PET imaging

T2 - Standardization and integration with other Alzheimer’s disease biomarkers

AU - Morbelli, Silvia

AU - Bauckneht, Matteo

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Amyloid plaques are a neuropathologic hallmark of Alzheimer’s disease (AD), which can be imaged through positron emission tomography (PET) technology using radiopharmaceuticals that selectively bind to the fibrillar aggregates of amyloid-β plaques (Amy-PET). Several radiotracers for amyloid PET have been investigated, including 11C-Pittsburgh compound B and the 18F-labeled compounds such as 18F-florbetaben, 18F-florbetapir, and 18F-flutemetamol. Besides the injected radiotracer, images can be interpreted by means of visual/qualitative, semiquantitative, and quantitative criteria. Here we summarize the main differences between the available radiotracers for Amy-PET, the proposed interpretation criteria, and analytical methods.

AB - Amyloid plaques are a neuropathologic hallmark of Alzheimer’s disease (AD), which can be imaged through positron emission tomography (PET) technology using radiopharmaceuticals that selectively bind to the fibrillar aggregates of amyloid-β plaques (Amy-PET). Several radiotracers for amyloid PET have been investigated, including 11C-Pittsburgh compound B and the 18F-labeled compounds such as 18F-florbetaben, 18F-florbetapir, and 18F-flutemetamol. Besides the injected radiotracer, images can be interpreted by means of visual/qualitative, semiquantitative, and quantitative criteria. Here we summarize the main differences between the available radiotracers for Amy-PET, the proposed interpretation criteria, and analytical methods.

KW - Alzheimer’s disease

KW - Amyloid PET

KW - Biomarkers

KW - Brain

UR - http://www.scopus.com/inward/record.url?scp=85043456362&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85043456362&partnerID=8YFLogxK

U2 - 10.1007/978-1-4939-7704-8_13

DO - 10.1007/978-1-4939-7704-8_13

M3 - Chapter

AN - SCOPUS:85043456362

T3 - Methods in Molecular Biology

SP - 203

EP - 212

BT - Methods in Molecular Biology

PB - Humana Press Inc.

ER -